Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Phase 1 study of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase in patients with relapsed/refractory leukemia
Comparative studies of single-peptide versus multi-peptide activity on fibroblast migration, proliferation, and extracellular matrix deposition
This condition requires comprehensive treatment to support hair regrowth and emotional well-being
Depending on your body's needs, the results can last from one week to a month
ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model
This study has several limitations that should be acknowledged
US$ 23.70
US$ 22.78
US$ 22.86
US$ 29.53
US$ 25.39
